Compass Therapeutics, Inc.
CMPX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $0K | $850K | −100% |
| Operating income | −$72.8M | −$56.6M | −28.6% |
| Net income | −$66.5M | −$49.4M | −34.6% |
Questions
- What was Compass Therapeutics's revenue in FY2025?
- $0K in FY2025 (Fiscal year ended Dec 31, 2025), −100% vs $850K a year earlier, per its 10-K filed Mar 2026.
- Was Compass Therapeutics profitable in FY2025?
- No: net income was −$66.5M and operating income −$72.8M in FY2025.